secwatch.observer — SEC 8-K summary
======================================

Issuer:     Virpax Pharmaceuticals, Inc. (—)
CIK:        0001708331
Form:       8-K
Filed at:   2025-03-21T23:59:59+00:00
Accession:  0001731122-25-000427
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Virpax Pharmaceuticals effects 1-for-25 reverse stock split effective March 21, 2025
--------------------------------------------------------------------------------

- Reverse split ratio set at 1-for-25, effective 12:01 a.m. ET on March 21, 2025.
- Outstanding shares reduced from 31,062,581 to 1,242,504.
- Trading symbol VRPX unchanged; new CUSIP 928251305.
- Board approved final ratio on March 5, 2025, following stockholder authorization on January 15, 2025.
- Equity awards and warrants proportionally adjusted for the split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708331/000173112225000427/0001731122-25-000427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708331/000173112225000427/e6439_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-000427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer